Literature DB >> 21531049

Synthesis, antitumor and antimicrobial activities of 4-(4-chlorophenyl)-3-cyano-2-(β-O-glycosyloxy)-6-(thien-2-yl)-nicotinonitrile.

Hassan A El-Sayed1, Ahmed H Moustafa, Abd El-Fattah Z Haikal, Rajab Abu-El-Halawa, El Sayed H El Ashry.   

Abstract

4-(4-Chlorophenyl)-3-cyano-6-(thien-2-yl)-1H-pyridin-2-one (2) was obtained by reaction of 2-acetyl thiophene with 4-chlorobenzaldehyde and ethyl cyanoacetate in presence of ammonium acetate or by the reaction of α,β-unsaturated compound 1 with ethyl cyanoacetate in the presence of ammonium acetate. 4-(4-Chlorophenyl)-2-(2',3',4',6'-tetra-O-acetyl-β-d-gluco/galactopyranosyloxy)-6-(thien-2-yl)nicotinonitrile (5a and 5b), riboside 11, xyloside 12 and lactoside 16 were prepared by the reaction of 2 with glycosyl/galactosyl/xylosyl/lactosyl bromide and peracetylated xylose/ribose under the conventional and microwave irradiation methods. The reaction has regioselectively gave the O-glycosides and not the N-glycosides. The glycosides 5a,b, riboside 11, xyloside 12 and lactoside 16 were deacetylated in the presence of Et(3)N/MeOH and few drops of water to give 7a,b, 13, 14 and 17. The structure of the new synthesized compounds was confirmed by using IR, (1)H, (13)C NMR spectra and microanalysis. Selected members of these compounds were screened for antitumor and antibacterial activity.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531049     DOI: 10.1016/j.ejmech.2011.04.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Crystal structure of 2-benzyl-amino-4-(4-bromo-phen-yl)-6,7-di-hydro-5H-cyclo-penta-[b]pyridine-3-carbo-nitrile.

Authors:  R A Nagalakshmi; J Suresh; S Maharani; R Ranjith Kumar; P L Nilantha Lakshman
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-21

2.  6-(4-Amino-phen-yl)-2-meth-oxy-4-phenyl-nicotino-nitrile.

Authors:  Thitipone Suwunwong; Suchada Chantrapromma; Ching Kheng Quah; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-23

3.  New 3-Cyano-2-Substituted Pyridines Induce Apoptosis in MCF 7 Breast Cancer Cells.

Authors:  Ahmed Malki; Mona Mohsen; Hassan Aziz; Ola Rizk; Omima Shaban; Mohamed El-Sayed; Zaki A Sherif; Hayam Ashour
Journal:  Molecules       Date:  2016-02-18       Impact factor: 4.411

4.  Synthesis and biological evaluation of 2-oxonicotinonitriles and 2-oxonicotinonitrile based nucleoside analogues.

Authors:  Reham A I Abou-Elkhair; Ahmed H Moustafa; Abdelfattah Z Haikal; Ahmed M Ibraheem
Journal:  Eur J Med Chem       Date:  2014-01-08       Impact factor: 6.514

5.  6-(4-Amino-phen-yl)-4-(4-eth-oxy-phen-yl)-2-meth-oxy-nicotinonitrile.

Authors:  Thitipone Suwunwong; Suchada Chantrapromma; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-31

6.  6-Meth-oxy-4-(2,4,5-tri-meth-oxy-phen-yl)-2,2'-bi-pyridine-5-carbo-nitrile.

Authors:  Suchada Chantrapromma; Thitipone Suwunwong; Pumsak Ruanwas; Ching Kheng Quah; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-04

7.  Crystal structure of 2-(2-bromo-phen-yl)-4-(1H-indol-3-yl)-6-(thio-phen-2-yl)pyridine-3-carbo-nitrile.

Authors:  R Vishnupriya; J Suresh; Shanmugavel Bharkavi; Subbu Perumal; P L Nilantha Lakshman
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-01

8.  Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine⁻Pyrazole Hybrid Derivatives.

Authors:  Eman M Flefel; Walaa I El-Sofany; Mahmoud El-Shahat; Arshi Naqvi; Eman Assirey
Journal:  Molecules       Date:  2018-10-06       Impact factor: 4.411

9.  Facile synthesis and antiproliferative activity of new 3-cyanopyridines.

Authors:  Hassan M Abdel-Aziz; Sobhi M Gomha; Abdelaziz A El-Sayed; Yahia Nasser Mabkhot; Abdulrhman Alsayari; Abdullatif Bin Muhsinah
Journal:  BMC Chem       Date:  2019-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.